News on Mylan Laboratories from BioPortfolio.com http://www.BioPortfolio.com Consolidated Mylan Laboratories news from BioPortfolio.com Tue, 09 Feb 2010 23:24:43 GMT en Mylan Confirms First-to-File Patent Challenge Relating to Caduethttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037766&HITNO=0&MSIZE=487&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Mylan%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037766&THISHREF=http://c.moreover.com/click/here.pl%3fz2537277134%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037766&HITNO=0&MSIZE=487&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Mylan%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037766&THISHREF=http://c.moreover.com/click/here.pl%3fz2537277134%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: GeoVax Labs provides updates on HIV-1 vaccine trialshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033398&HITNO=1&MSIZE=487&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Mylan%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033398&THISHREF=http://c.moreover.com/click/here.pl%3fz2535181878%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033398&HITNO=1&MSIZE=487&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Mylan%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033398&THISHREF=http://c.moreover.com/click/here.pl%3fz2535181878%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Mylan New Zealand Limited (formerly Pacific Pharmaceuticals Ltd)-Company Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027194&HITNO=2&MSIZE=487&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Mylan%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027194&THISHREF=http://c.moreover.com/click/here.pl%3fz2531904857%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027194&HITNO=2&MSIZE=487&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Mylan%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027194&THISHREF=http://c.moreover.com/click/here.pl%3fz2531904857%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Mylan Confirms First-to-File Patent Challenge Relating to Caduethttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4025337&HITNO=3&MSIZE=487&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Mylan%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4025337&THISHREF=http://c.moreover.com/click/here.pl%3fz2529671540%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4025337&HITNO=3&MSIZE=487&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Mylan%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4025337&THISHREF=http://c.moreover.com/click/here.pl%3fz2529671540%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceuticalProcessing: Earnings Growth Proves Drugmaker Made Right Moveshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018331&HITNO=4&MSIZE=487&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Mylan%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018331&THISHREF=http://c.moreover.com/click/here.pl%3fz2525603767%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018331&HITNO=4&MSIZE=487&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Mylan%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018331&THISHREF=http://c.moreover.com/click/here.pl%3fz2525603767%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Earnings Growth Proves Drugmaker Made Right Moveshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018245&HITNO=5&MSIZE=487&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Mylan%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018245&THISHREF=http://c.moreover.com/click/here.pl%3fz2525539064%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018245&HITNO=5&MSIZE=487&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Mylan%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018245&THISHREF=http://c.moreover.com/click/here.pl%3fz2525539064%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! News: Mylan Confirms First-to-File Patent Challenge Relating to Caduet(R)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018046&HITNO=6&MSIZE=487&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Mylan%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018046&THISHREF=http://c.moreover.com/click/here.pl%3fz2525447575%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018046&HITNO=6&MSIZE=487&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Mylan%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018046&THISHREF=http://c.moreover.com/click/here.pl%3fz2525447575%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Mylan first to file ANDA patent for Caduet Tabletshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019355&HITNO=7&MSIZE=487&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Mylan%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019355&THISHREF=http://c.moreover.com/click/here.pl%3fz2526241775%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019355&HITNO=7&MSIZE=487&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Mylan%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019355&THISHREF=http://c.moreover.com/click/here.pl%3fz2526241775%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Mylan Confirms First-to-File Patent Challenge Relating to Caduethttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020741&HITNO=8&MSIZE=487&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Mylan%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020741&THISHREF=http://c.moreover.com/click/here.pl%3fz2526986607%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020741&HITNO=8&MSIZE=487&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Mylan%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020741&THISHREF=http://c.moreover.com/click/here.pl%3fz2526986607%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: Kirby McInerney LLP Wins City of New York and New York Counties' Affirmative Summary Judgment in Medicaid Fraud Case Against 11 Generic Drug Manufacturers: Court Finds That Defendants Knowingly Rhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4023212&HITNO=9&MSIZE=487&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Mylan%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4023212&THISHREF=http://c.moreover.com/click/here.pl%3fz2528094455%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4023212&HITNO=9&MSIZE=487&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Mylan%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4023212&THISHREF=http://c.moreover.com/click/here.pl%3fz2528094455%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: Kirby McInerney LLP Wins City of New York and New York Counties Affirmative Summary Judgment in Medicaid Fraud Case Against 11 Generic Drug Manufacturers: Court Finds That Defendants Knowingly Rhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4023205&HITNO=10&MSIZE=487&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Mylan%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4023205&THISHREF=http://c.moreover.com/click/here.pl%3fz2528089340%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4023205&HITNO=10&MSIZE=487&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Mylan%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4023205&THISHREF=http://c.moreover.com/click/here.pl%3fz2528089340%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: Noven Appoints Patrick Gallagher as Vice Presidenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4011901&HITNO=11&MSIZE=487&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Mylan%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4011901&THISHREF=http://c.moreover.com/click/here.pl%3fz2523148654%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4011901&HITNO=11&MSIZE=487&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Mylan%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4011901&THISHREF=http://c.moreover.com/click/here.pl%3fz2523148654%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comHealthcare Sales & Marketing Network: Noven Appoints Patrick Gallagher as Vice President of Business Developmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4009572&HITNO=12&MSIZE=487&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Mylan%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4009572&THISHREF=http://c.moreover.com/click/here.pl%3fz2522024318%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4009572&HITNO=12&MSIZE=487&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Mylan%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4009572&THISHREF=http://c.moreover.com/click/here.pl%3fz2522024318%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Pfizer files infringement suit against Mylan for Caduet generichttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4015972&HITNO=13&MSIZE=487&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Mylan%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4015972&THISHREF=http://c.moreover.com/click/here.pl%3fz2524593671%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4015972&HITNO=13&MSIZE=487&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Mylan%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4015972&THISHREF=http://c.moreover.com/click/here.pl%3fz2524593671%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDrug Store News: Mylan Confirms First-to-File Patent Challenge Relating to Caduet(...http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4015126&HITNO=14&MSIZE=487&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Mylan%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4015126&THISHREF=http://c.moreover.com/click/here.pl%3fz2524287536%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4015126&HITNO=14&MSIZE=487&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Mylan%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4015126&THISHREF=http://c.moreover.com/click/here.pl%3fz2524287536%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comZibb: